WORLD Egypt receives raw materials to produce Sinovac COVID-19 vaccine

WORLD

Egypt receives raw materials to produce Sinovac COVID-19 vaccine

Xinhua

06:42, May 24, 2021

CAIRO, May 23 (Xinhua) -- Egypt has received the first batch of the raw materials to manufacture China's Sinovac vaccine, said the Chinese embassy in Egypt on Sunday.

Airport staff transport the first batch of Chinese Sinovac vaccine raw materials unloaded from a palne at the Cairo International Airport in Cairo, Egypt, May 21, 2021. (Xinhua/Sui Xiankai)

Along with the Sinovac raw materials, a new shipment of China's Sinopharm COVID-19 vaccines also arrived at the Cairo International Airport on Friday, according to a Chinese embassy's statement.

Egyptian Health Minister Hala Zayed said on May 9 that Egypt will start locally producing Sinovac COVID-19 vaccine in June, and the first 2 million doses will be produced at the plants of the Egyptian Holding Company for Biological Products and Vaccines (VACSERA).

The local end-product will be distributed to medical centers across Egypt in two months after being assessed by the Egyptian Drug Authority, said Zayed at a press conference at the airport.

"VACSERA will produce more than 5 million doses of Sinovac vaccine in two months, and 40 million doses within a year," she said.

Zayed hailed the arrival of a new shipment of Sinopharm and raw materials of Sinovac vaccine as ushering in "a new chapter of bilateral ties," and the best way to celebrate the 65th anniversary of the establishment of diplomatic ties between the two countries.

China has made remarkable contributions to Egypt's diversification of vaccine sources and promoting the country's economic recovery in the post-pandemic era, she stressed.

After meeting Egypt's own needs, vaccines produced in Egypt will be exported to other countries in the Middle East and Africa to help fight the pandemic, said the Egyptian minister.

Vaccine cooperation has laid a good foundation for Egypt and China to expand medical and health cooperation, Zayed said, adding that the two countries will boost cooperation in medical technology transfer and strive for more results to benefit the two peoples.

The two countries' joint efforts in fighting COVID-19 have not only deepened the traditional friendship and political mutual trust, but also set an example for the international community, Zayed noted.

For his part, Chinese Ambassador to Egypt Liao Liqiang said that, as Egypt receives the Sinovac vaccine raw materials, it becomes the first country on the African continent to cooperate with China in producing the COVID-19 vaccines.

"This is very important for the early prevail over the pandemic not only in Egypt, but also in the whole African continent and the Arab region," Liao said.

China calls on the international community to lend more hands to Africa through providing epidemic prevention materials, medicines, technology and funds to ensure the accessibility and affordability of vaccines, Liao said.

He reiterated that China has always been a staunch supporter of Africa in fighting the pandemic, an active participant in the continent's development and revitalization, and a strong defender of peace and stability.

Egypt started in late January vaccinating the medical staff of governmental hospitals with a COVID-19 vaccine made by another leading Chinese drugmaker Sinopharm, which is the first vaccine approved by the Egyptian Drug Authority.

In early March, the most populous Arab country began to vaccinate elderly people and patients with chronic diseases against the highly infectious coronavirus.

So far, Egypt has reported 252,690 COVID-19 cases, including 14,670 deaths and 186,223 recoveries.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue